Van ECK Associates Corp grew its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 72.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 150,285 shares of the company's stock after purchasing an additional 63,253 shares during the period. Van ECK Associates Corp owned about 0.07% of Bath & Body Works worth $5,827,000 at the end of the most recent quarter.
A number of other institutional investors have also made changes to their positions in the business. Golden State Wealth Management LLC acquired a new position in shares of Bath & Body Works during the 4th quarter worth approximately $26,000. UMB Bank n.a. increased its holdings in Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company's stock worth $35,000 after buying an additional 335 shares during the last quarter. True Wealth Design LLC raised its position in Bath & Body Works by 5,270.0% during the third quarter. True Wealth Design LLC now owns 1,074 shares of the company's stock worth $34,000 after acquiring an additional 1,054 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in Bath & Body Works in the third quarter valued at $39,000. Finally, Friedenthal Financial bought a new position in shares of Bath & Body Works in the 4th quarter valued at about $57,000. Institutional investors own 95.14% of the company's stock.
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on the stock. Wells Fargo & Company raised shares of Bath & Body Works from an "equal weight" rating to an "overweight" rating and upped their target price for the company from $42.00 to $48.00 in a report on Friday, January 10th. Barclays upped their price objective on Bath & Body Works from $28.00 to $34.00 and gave the company an "underweight" rating in a research note on Tuesday, November 26th. Argus reaffirmed a "hold" rating on shares of Bath & Body Works in a research report on Friday, January 10th. Morgan Stanley decreased their target price on Bath & Body Works from $51.00 to $48.00 and set an "overweight" rating on the stock in a report on Thursday, November 21st. Finally, TD Cowen raised their price target on Bath & Body Works from $42.00 to $48.00 and gave the company a "buy" rating in a report on Thursday, December 12th. One research analyst has rated the stock with a sell rating, five have given a hold rating and eleven have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $43.63.
Read Our Latest Stock Report on Bath & Body Works
Bath & Body Works Trading Down 4.5 %
NYSE BBWI traded down $1.84 during trading on Friday, reaching $38.51. The company's stock had a trading volume of 5,441,380 shares, compared to its average volume of 3,304,652. The firm has a 50 day moving average price of $37.70 and a 200 day moving average price of $33.86. Bath & Body Works, Inc. has a 12 month low of $26.20 and a 12 month high of $52.99. The firm has a market capitalization of $8.34 billion, a price-to-earnings ratio of 9.39, a price-to-earnings-growth ratio of 0.95 and a beta of 1.83.
Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business had revenue of $1.61 billion during the quarter, compared to analysts' expectations of $1.58 billion. During the same period in the previous year, the company posted $0.48 earnings per share. The firm's revenue for the quarter was up 3.1% compared to the same quarter last year. On average, equities analysts forecast that Bath & Body Works, Inc. will post 3.26 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, March 7th. Investors of record on Friday, February 21st will be paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 2.08%. The ex-dividend date of this dividend is Friday, February 21st. Bath & Body Works's dividend payout ratio (DPR) is presently 19.51%.
Bath & Body Works Company Profile
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Articles

Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.